Ram M. Jagannath
Ram Jagannath is a Managing Director at The Carlyle Group focused on investment opportunities in the healthcare sector. He is based in New York.
Since joining Carlyle in 2007, Mr. Jagannath has been actively involved in investing over $5 billion of equity into healthcare companies globally. He currently sits on the Board of Directors of One Medical, Ortho Clinical Diagnostics, Pharmaceutical Product Development (PPD), and X-Co (parent company of X-Chem and X-Rx). He was previously involved in Carlyle’s realized investments in Healthscope Ltd. and HCR ManorCare. Mr. Jagannath was also a term member of the Council on Foreign Relations.
Prior to joining Carlyle, Mr. Jagannath was with Genstar Capital and Thomas Weisel Capital Partners (now Tailwind Capital) in San Francisco.
Mr. Jagannath received an M.B.A. from Northwestern University Kellogg School of Management, a J.D. from Northwestern University School of Law and a B.S.E. in biomedical and electrical engineering with a minor in economics from Duke University. After Duke, he completed post-graduate research in economic development as a Fulbright Scholar at the University of Zagreb in Croatia.